The Related Factors With Resilience in Caregivers Whose Child With Leukemia

This study is enrolling participants by invitation only.
Information provided by:
China Medical University Hospital Identifier:
First received: November 26, 2010
Last updated: NA
Last verified: November 2010
History: No changes posted
The purpose of this study was to explore caregivers stress, family functioning, social support and family resilience of families whose children had acute lymphoblastic leukemia. The significantly correlation among caregivers stress, family functioning, social support and family resilience was also explored.

Condition 1. Children With ALL Are Still Alive and the Age of 18 Years of Age.
Condition 2. Has Been Completed to Guide the Treatment Regimen Were in Remission.
Condition 3. Caregiver Can or Taiwanese Language Communicator.

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional

Resource links provided by NLM:

Further study details as provided by China Medical University Hospital:

Estimated Enrollment: 50
Study Start Date: September 2010
resilience in caregivers whose child with ALL


Ages Eligible for Study:   up to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Families of children was diagnosed acute lymphoblastic leukemia

Inclusion Criteria:

  1. Diagnosed as acute lymphoblastic leukemia children, children with cancer are still alive and the age of 18 years of age.
  2. Has been completed to guide the treatment regimen were in remission.
  3. Caregiver can or Taiwanese language communicator.

Exclusion Criteria:

- Children with metastatic cancer who end chemical treatment of more than one year

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01249781

China Medical University Hospital
Taichung, No.2 Yuh Der Road, Taiwan
Sponsors and Collaborators
China Medical University Hospital
  More Information

Responsible Party: China Medical University Hospital, China Medical University Identifier: NCT01249781     History of Changes
Other Study ID Numbers: DMR-99-IRB-191 
Study First Received: November 26, 2010
Last Updated: November 26, 2010
Health Authority: Taiwan: The Institutional Review Bord China Medical University Hospital

Additional relevant MeSH terms:
Pathologic Processes processed this record on May 30, 2016